116 related articles for article (PubMed ID: 15144349)
1. Tibolone.
Reynir Tomas G
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):606. PubMed ID: 15144349
[No Abstract] [Full Text] [Related]
2. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
[No Abstract] [Full Text] [Related]
3. The LIBERATE tibolone trial in breast cancer survivors.
Speroff L
Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
[No Abstract] [Full Text] [Related]
4. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
5. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Biglia N; Maffei S; Lello S; Nappi RE
Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
[TBL] [Abstract][Full Text] [Related]
6. Does tibolone exacerbate atherosclerosis?
Clarkson TB
Eur Heart J; 2006 Mar; 27(6):635-7. PubMed ID: 16415302
[No Abstract] [Full Text] [Related]
7. What have we really learned from 'LIBERATE' trial?
Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A
Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777
[TBL] [Abstract][Full Text] [Related]
8. Endometrial cancer--surprising reports.
Speroff L
Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
[No Abstract] [Full Text] [Related]
9. Hormone replacement therapy in women with past history of endometriosis.
Soliman NF; Hillard TC
Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
[TBL] [Abstract][Full Text] [Related]
10. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
11. Tibolone-induced acute hepatitis: Well-known drug, little-known complication.
Macedo G; Silva M; Vilas-Boas F; Lopes S; Peixoto A; Carneiro F
Gastroenterol Hepatol; 2017 Apr; 40(4):298-300. PubMed ID: 27093896
[No Abstract] [Full Text] [Related]
12. Carcinoma of the endometrium in patients treated with tibolone.
Yazigi R; Sahid S; Contreras L; Rodriguez T
Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
[TBL] [Abstract][Full Text] [Related]
13. Endometrial adenocarcinoma after prolonged tibolone therapy.
Nassar AH; Khalil AM; Seoud MA; Usta IM
Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
[No Abstract] [Full Text] [Related]
14. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
[TBL] [Abstract][Full Text] [Related]
15. Tibolone and breast cancer risk: effects of selection bias cannot be eliminated in observational studies.
Coomarasamy A
BJOG; 2008 Jun; 115(7):919. PubMed ID: 18485174
[No Abstract] [Full Text] [Related]
16. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
[TBL] [Abstract][Full Text] [Related]
17. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth].
Carranza Lira S
Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511
[TBL] [Abstract][Full Text] [Related]
18. By the way, doctor. What happened to tibolone--the estrogen alternative we heard about a while ago? Did it turn out not to be effective?
Robb-Nicholson C
Harv Womens Health Watch; 2004 Apr; 11(8):8. PubMed ID: 15100062
[No Abstract] [Full Text] [Related]
19. [Tibolone-induced hepatotoxicity].
Blanco Sampascual S; de Las Heras Niño B; Cabezudo Gil P; Ruiz Eguiluz P; Orive Cura V
Gastroenterol Hepatol; 2002 Apr; 25(4):274. PubMed ID: 11975880
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator.
Campisi R; Marengo FD
Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]